As a pioneer in the field of MRI conditionality, MicroPort CRM offers a solution that enables safe MRI scans for patients using MicroPort-selected pacemakers paired with compatible leads from selected manufacturers*.
This marks another step on MicroPort’s continuous innovation path in this field, starting 12 years ago as the first manufacturer to introduce a solution to improve MRI management with AUTOMRI™.
*Pacemaker system. Refer to MRI Solutions Manuals available online at microportmanuals.com
EXPAND COMPATIBLE LEADS SELECTION
EXPAND MRI BENEFITS TO MORE PATIENTS
Traditionally, MRI safety has been limited to devices and leads from the same manufacturer. MicroPort is revolutionising this space by offering an innovative compatibility assessment that expands pacemaker patient’s access to MRI imaging.
Provide physicians the flexibility of choosing from an extended MR conditional lead compatibility range.
RIGOROUSLY TESTED AND APPROVED
FOR ENHANCED CONFIDENCE
Our experts ensure that more patients can undergo MRI scans without compromising safety.
Our engineers tested the non-MicroPort leads under the same conditions as our own, ensuring consistent performance.
MR CONDITIONAL SYSTEM SUPPORTING LBBAP LEADS
Approved for LBBAP ensuring physiological pacing, ALIZEA™, BOREA™ and CELEA™ when combined with selected MR conditional third-party leads positioned in left bundle branch area constitutes an MR conditional system.
SAME OUTSTANDING ALIZEA FEATURES
MORE MRI LEADS COMPATIBLE
Benefit from ALIZEA™ outstanding features with the advantage of extended MR conditional lead options.
ALIZEA™ enhances physiological pathways supported by LBBAP approval while preserving natural conduction thanks to SafeR™.
In a world where interventions are a physical, psychological and financial burden for patients, ALIZEA™ provides up to 13 years longevity with remote monitoring and all features activated.
2014 innovation award for AUTOMRI™ technology.
Longest experience in automatic MRI detection.
AUTOMRI™ is available in all Microport™ CRM MR-conditional devices.
- Patients are protected with optimal detection and treatment right up to and just after the scan
- Protects the patient by keeping their time in asynchronous mode to an absolute minimum
- Ensures patients don't leave the hospital with sub-optimal settings
- Patients are protected with optimal detection and treatment right up to and just after the scan,
- Protects the patient by keeping their time in asynchronous mode to an absolute minimum,
- Ensures patients don't leave the hospital with sub-optimal settings.
10-day scan windows.
No limitation on the number of scans during these 10 days and no need to return to the cardiologist for any additional check-ups.
Approaching and detecting the scanner, the device switched into asynchronous MRI mode. For tachy devices, the essential therapies (ATP + shock) are only deactivated during the scan.
Moving away from the scanner, 5 minutes after your patient leaves the MRI environment, the device switches back to the initial settings without any HCP intervention.
The patient is free to go home autonomously.
Verify the Magnetic Resonance Imaging (MRI) compatibility of the implanted MicroPort CRM device.
A complete Magnetic Resonance (MR) conditional pacing system consists of an MR approved combination of a cardiac implantable device with appropriate lead(s).
Any MicroPort CRM device that is not available for selection is not compatible with MRI scans.
Now featuring extended MRI lead compatibility beyond MicroPort leads.
The CAPRI study is an interventional, prospective, multicenter, open label, two arms parallel non-comparative study conducted in Europe and Asia-Pacific that aims to evaluate the clinical safety and performance of MicroPort Pacing systems, using the AUTOMRI™ algorithm, under 1.5T and 3T MRI, as well as the image quality of the scans.
We are dedicated to improving and reshaping patient lives through the application of innovative CRM science and technology.
We understand the need to inform patients about their upcoming MRI scan, accompanying them and responding to their questions and worries.
Disclaimer: This website provides information on the MR compatibility of the implanted system. Prior to the scan, please read the complete instruction for use in the device MRI Solutions Manual available online at www.microportmanuals.com. The device must be programmed to enable the MRI Mode during MRI examination. All trademarks, logos and brand names that are not specifically proprietary to the MicroPort group, are the property of their respective owners.
The products and combination of products may not be approved for sale in the USA, Japan and other geographies. Contact your MicroPort CRM representative for more information.
This website is not available in France.
